Cargando…
Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer
BACKGROUND: Although transplant benefit appears superior for patients with advanced hepatocellular cancer (HCC), liver transplantation remains limited to selected low-risk HCC patients to keep their outcomes similar to heterogeneous group of non-HCC patients. The purpose of this study was to assess...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596049/ https://www.ncbi.nlm.nih.gov/pubmed/28695391 http://dx.doi.org/10.1245/s10434-017-5989-x |
_version_ | 1783263470953693184 |
---|---|
author | Grąt, Michał Stypułkowski, Jan Patkowski, Waldemar Wronka, Karolina M. Bik, Emil Krasnodębski, Maciej Masior, Łukasz Lewandowski, Zbigniew Wasilewicz, Michał Grąt, Karolina Krawczyk, Marek Zieniewicz, Krzysztof |
author_facet | Grąt, Michał Stypułkowski, Jan Patkowski, Waldemar Wronka, Karolina M. Bik, Emil Krasnodębski, Maciej Masior, Łukasz Lewandowski, Zbigniew Wasilewicz, Michał Grąt, Karolina Krawczyk, Marek Zieniewicz, Krzysztof |
author_sort | Grąt, Michał |
collection | PubMed |
description | BACKGROUND: Although transplant benefit appears superior for patients with advanced hepatocellular cancer (HCC), liver transplantation remains limited to selected low-risk HCC patients to keep their outcomes similar to heterogeneous group of non-HCC patients. The purpose of this study was to assess the rationale for current policy of restricting access to liver transplantation to minority of HCC patients based on utility principle. METHODS: This retrospective cohort study comprised 1246 liver transplant recipients, including 206 HCC and 1040 non-HCC patients. Patient survival was the primary outcome measure. Patients with HCC and benign diseases were divided into low-, moderate-, and high-risk subgroups basing on independent risk factors for disease-free survival and model for end-stage liver disease (MELD) score (<30, 30–40, >40), respectively. RESULTS: MELD (p < 0.001) and presence of HCC (p = 0.008) were independent risk factors for early and late mortality, respectively. Total tumor volume (p = 0.008) and alpha-fetoprotein (p = 0.013) were independent predictors of recurrence and mortality used for division of HCC patients into low-, moderate-, and high-risk subgroups, with disease-free survival rates of 74.9% (5 years), 51.7% (5 years), and 8.0% (3 years), respectively (p < 0.001). There were no differences in 5-year overall survival between low-risk HCC (74.9%) and non-HCC (81.9%) patients (p = 0.210), moderate-risk HCC (63.3%) and non-HCC (68.0%) patients (p = 0.372), and high-risk HCC (55.0%) and non-HCC (56.0%) patients (p = 0.559). CONCLUSIONS: The principle of utility is unequally applied for restriction of access to liver transplantation for HCC patients. The results provide rationale for discussion on reinitiation of liver transplantation for advanced HCCs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1245/s10434-017-5989-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5596049 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-55960492017-09-26 Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer Grąt, Michał Stypułkowski, Jan Patkowski, Waldemar Wronka, Karolina M. Bik, Emil Krasnodębski, Maciej Masior, Łukasz Lewandowski, Zbigniew Wasilewicz, Michał Grąt, Karolina Krawczyk, Marek Zieniewicz, Krzysztof Ann Surg Oncol Hepatobiliary Tumors BACKGROUND: Although transplant benefit appears superior for patients with advanced hepatocellular cancer (HCC), liver transplantation remains limited to selected low-risk HCC patients to keep their outcomes similar to heterogeneous group of non-HCC patients. The purpose of this study was to assess the rationale for current policy of restricting access to liver transplantation to minority of HCC patients based on utility principle. METHODS: This retrospective cohort study comprised 1246 liver transplant recipients, including 206 HCC and 1040 non-HCC patients. Patient survival was the primary outcome measure. Patients with HCC and benign diseases were divided into low-, moderate-, and high-risk subgroups basing on independent risk factors for disease-free survival and model for end-stage liver disease (MELD) score (<30, 30–40, >40), respectively. RESULTS: MELD (p < 0.001) and presence of HCC (p = 0.008) were independent risk factors for early and late mortality, respectively. Total tumor volume (p = 0.008) and alpha-fetoprotein (p = 0.013) were independent predictors of recurrence and mortality used for division of HCC patients into low-, moderate-, and high-risk subgroups, with disease-free survival rates of 74.9% (5 years), 51.7% (5 years), and 8.0% (3 years), respectively (p < 0.001). There were no differences in 5-year overall survival between low-risk HCC (74.9%) and non-HCC (81.9%) patients (p = 0.210), moderate-risk HCC (63.3%) and non-HCC (68.0%) patients (p = 0.372), and high-risk HCC (55.0%) and non-HCC (56.0%) patients (p = 0.559). CONCLUSIONS: The principle of utility is unequally applied for restriction of access to liver transplantation for HCC patients. The results provide rationale for discussion on reinitiation of liver transplantation for advanced HCCs. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1245/s10434-017-5989-x) contains supplementary material, which is available to authorized users. Springer International Publishing 2017-07-10 2017 /pmc/articles/PMC5596049/ /pubmed/28695391 http://dx.doi.org/10.1245/s10434-017-5989-x Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Hepatobiliary Tumors Grąt, Michał Stypułkowski, Jan Patkowski, Waldemar Wronka, Karolina M. Bik, Emil Krasnodębski, Maciej Masior, Łukasz Lewandowski, Zbigniew Wasilewicz, Michał Grąt, Karolina Krawczyk, Marek Zieniewicz, Krzysztof Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer |
title | Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer |
title_full | Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer |
title_fullStr | Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer |
title_full_unstemmed | Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer |
title_short | Challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer |
title_sort | challenging the principle of utility as a barrier for wider use of liver transplantation for hepatocellular cancer |
topic | Hepatobiliary Tumors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596049/ https://www.ncbi.nlm.nih.gov/pubmed/28695391 http://dx.doi.org/10.1245/s10434-017-5989-x |
work_keys_str_mv | AT gratmichał challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT stypułkowskijan challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT patkowskiwaldemar challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT wronkakarolinam challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT bikemil challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT krasnodebskimaciej challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT masiorłukasz challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT lewandowskizbigniew challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT wasilewiczmichał challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT gratkarolina challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT krawczykmarek challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer AT zieniewiczkrzysztof challengingtheprincipleofutilityasabarrierforwideruseoflivertransplantationforhepatocellularcancer |